|
|
Volumn 3, Issue 7, 2004, Pages 542-543
|
|
Lessons learnt from Genasense's failure
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIUM;
DACARBAZINE;
GALLIUM NITRATE;
OBLIMERSEN;
TEMOZOLOMIDE;
ANTINEOPLASTIC ACTIVITY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DISEASE COURSE;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG WITHDRAWAL;
EXPECTATION;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPERCALCEMIA;
MEDICAL ASSESSMENT;
MEDICAL DECISION MAKING;
MELANOMA;
NOTE;
PRIORITY JOURNAL;
TIME;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
|
EID: 3543128235
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd1464 Document Type: Note |
|
Times cited : (21)
|
|
References (0)
|